Siyi Li

ORCID: 0009-0001-9564-8840 · 3 papers in corpus
observational 2026
Analysis of prognostic factors in ovarian clear cell carcinoma: a retrospective cohort study
Translational cancer research ·doi:10.21037/tcr-2025-1643

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is a rare histological subtype of ovarian cancer, often associated with endometrial lesions, and characterized by poor prognosis and a high propensity for recurrence and metastasis. This study…

lab-animal 2022
Using Patient-Derived Xenograft (PDX) Models as a 'Black Box' to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical Trial
Cancers ·doi:10.3390/cancers14194649

(1) The accuracy of patient-derived xenografts (PDXs) in predicting ADP-ribose polymerase inhibitor (PARPi) efficacy in ovarian cancer was tested, novel biomarkers were investigated, and whether PARPis could replace platinum-based chemother…

2020
Study on Traditional Chinese Medicine Prescription Rule in Adenomyosis Based on Data Mining